Gedeon Richter UK has announced the launch of Nalvee (10mg dydrogesterone) in the United Kingdom, marking the long-awaited return...
Read MoreMicrobiotica has announced the completion of patient recruitment for its Phase 1b clinical trial, COMPOSER-1, which is evaluating its...
Read MoreExonate has announced plans to advance its lead candidate, EXN407, into a Phase 2b clinical trial for non-proliferative diabetic...
Read MoreEisai has unveiled compelling new clinical data demonstrating that patients with early Alzheimer’s disease can experience sustained benefits from...
Read MoreKling Bio has announced a major step forward in the field of antibody discovery, unveiling a new collaboration and...
Read MoreAkari Therapeutics has reaffirmed its strategic focus on developing its novel PH1 spliceosome modulator payload, a promising innovation in...
Read More